News & Related Readings

Metaurus cross-lists its first ETFs in Mexico in LatAm push

Citywire

Metaurus Advisors Cross-Lists Two First-of-Their-Kind...

Press Release

Metaurus Advisors is Granted Patent for the First-Ever...

Press Release

Metaurus Advisors Rings The NYSE Closing Bell (5/23/19)...

NYSE-Arca

Former Wells Fargo Equities Head Rick Silva Lands...

Press Release

Wealth Management Award Finalist

Wealth Management

New ETF Focused on Buying S&P 500 at a “20% Discount”

ETF Trends

Metaurus “…carving out an interesting niche”

The Adventurous Investor

Metaurus Enters the ETF Fray

ETF Trends

Metaurus Advisors Launches Two Innovative ETFs...

Press Release

Primes and Scores: An Essay on Market Imperfections

Journal of Finance

ETFs
> IDIV - U.S. Dividend ETF
Fund Overview
Performance
Holdings
Factsheet & Prospectus

> XDIV - U.S. Ex-Dividend ETF
Fund Overview
Performance
Holdings
Factsheet & Prospectus

Portfolio Tools
> XDIV & IDIV Planner
> Portfolio Planner

About Us
> Our Team
> Mission
> Advantage
> Battle of Metaurus

Learn More
> Related Readings
> Solactive Indices
Solactive* U.S. Cumulative Dividend Index Series 2027
Solactive* U.S. Ex-Dividend Index Series 2027
> Disclosures

This material must be preceded or accompanied by a prospectus. Read the prospectus carefully before investing. The Funds are speculative securities and investing in them involves risk, including possible loss of principal. They are not investment companies registered under the Investment Company Act of 1940 and are not afforded its protections.

Other risk considerations are:

There is no guarantee that the Funds will meet its investment objective.
The Funds primarily invest in futures, which can be volatile. Even a small movement in market prices could cause large losses.
Restrictions on redemptions may affect your ability to withdraw your participation in the Funds. Because the Funds have designated maturity dates, new investors may elect not to invest in a Fund as it nears maturity and existing investors may elect to sell their Shares or redeem through an Authorized Participant. As a result, the size of each Fund may decrease as it nears maturity and the impact of fund expenses could increase as a result.
There is no guarantee that distributions will be made.
An active secondary market for Fund shares may not exist. Although the Funds will be listed on an exchange, subject to notice of issuance, it is possible that an active trading market may not develop or be maintained.
The Funds have limited operating history. Therefore, you do not have any performance history to serve as a factor for evaluating an investment in the securities.
Standardized performance numbers are available on the individual Fundsâ Fact Sheets.

Neither Metaurus Advisors LLC and its affiliates nor SEI and its affiliates provide tax advice. Please note that (i) any discussion of U.S. tax matters contained in this communication cannot be used by you for the purpose of avoiding tax penalties; (ii) this communication was written to support the promotion or marketing of the matters addressed herein: and (iii) you should seek advice based on your particular circumstances from an independent tax advisor.

Shares are bought and sold at market price (not NAV) and are not individually redeemed from the Funds other than in large Creation Unit aggregations. Instead, investors must buy or sell shares of a fund in the secondary market with the assistance of a broker. Buying and selling shares will result in brokerage commissions and will generate tax consequences. Brokerage commissions will reduce returns.

The Funds are distributed by SEI Investments Distribution Co (SIDCO), which is not affiliated with Metaurus Advisors LLC.

This site and its content are intended for U.S. investors only.

CME GROUP MARKET DATA IS USED UNDER LICENSE AS A SOURCE OF INFORMATION FOR CERTAIN METAURUS ADVISORS LLC PRODUCTS. CME GROUP HAS NO OTHER CONNECTION TO METAURUS ADVISORS LLC PRODUCTS AND SERVICES AND DOES NOT SPONSOR, ENDORSE, RECOMMEND OR PROMOTE ANY METAURUS ADVISORS LLC PRODUCTS OR SERVICES. CME GROUP HAS NO OBLIGATION OR LIABILITY IN CONNECTION WITH THE METAURUS ADVISORS LLC PRODUCTS AND SERVICES. CME GROUP DOES NOT GUARANTEE THE ACCURACY AND/OR THE COMPLETENESS OF ANY MARKET DATA LICENSED TO METAURUS ADVISORS LLC AND SHALL NOT HAVE ANY LIABILITY FOR ANY ERRORS, OMISSIONS, OR INTERRUPTIONS THEREIN. THERE ARE NO THIRD PARTY BENEFICIARIES OF ANY AGREEMENTS OR ARRANGEMENTS BETWEEN CME GROUP AND METAURUS ADVISORS LLC.